arrow
Back
A

Aman U. Buzdar

university of london

115H-index
720Paper Count
5.4WCitation Count
Published Papers 141
Publication Date
Clinical and Molecular Characteristics of HER2-low/zero Early Stage Triple-Negative Breast Cancer
err2023-03-01
err1
PREAI
errYam, Clinton; Li, Ziyi; Korkut, Anil; Ma, Wencai; Kong, Elisabeth; Hill, Holly A.; Abbas, Hussein; Abouharb, Sausan; Adrada, Beatriz; Arun, Banu K.; Barcenas, Carlos H.; Bisen, Ajit; Booser, Daniel; Buzdar, Aman; Candelaria, Rosalind; Chen, Junjie; Clayborn, Alyson; Damodaran, Senthil; Ding, Qingqing; Garber, Haven; Hortobagyi, Gabriel N.; Hunt, Kelly K.; Ibrahim, Nuhad K.; Iheme, Adaeze; Karuturi, Meghan S.; Koenig, Kimberly; Layman, Rachel M.; Lee, Jangsoon; Litton, Jennifer K.; Mitchell, Melissa; Moscol, Giancarlo; Mouabbi, Jason; Murthy, Rashmi K.; Oke, Oluchi; Pohlmann, Paula; Ramirez, David; Ravenberg, Elizabeth; Saleem, Sadia; Teshome, Mediget; Valero, Vicente; White, Jason; Williams, Madison; Woodward, Wendy; Yajima, Chasity; Ueno, Naoto T.; Chen, Ken; Rauch, Gaiane; Huo, Lei; Tripathy, Debu
errShare
errSave
Pharmacogenomics of aromatase inhibitors in postmenopausal breast cancer and additional mechanisms of anastrozole action
err2020-08-20
err24
errOAAI
errCairns, Junmei; Ingle, James N.; Dudenkov, Tanda M.; Kalari, Krishna R.; Carlson, Erin E.; Na, Jie; Buzdar, Aman U.; Robson, Mark E.; Ellis, Matthew J.; Goss, Paul E.; Shepherd, Lois E.; Goodnature, Barbara; Goetz, Matthew P.; Weinshilboum, Richard M.; Li, Hu; Bari, Mehrab Ghanat; Wang, Liewei
errShare
errSave
Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction Between SLC38A7 and ALPPL2
err2019-03-18
err10
errOAAI
errDudenkov, Tanda M.; Liu, Duan; Cairns, Juninei; Devarajan, Sandhva; Zhuang, Yongxian; Ingle, James N.; Buzdar, Aman U.; Robson, Mark E.; Kubo, Michiaki; Batzler, Anthony; Barman, Poulami; Jenkins, Greory D.; Carlson, Erin E.; Goetz, Matthew P.; Northfelt, Donald W.; Moreno-Aspitia, Alvaro; Desta, Zeruesenay; Reid, Joel M.; Kalari, Krishna R.; Wang, Liewei; Weinshilboum, Richard M.
errShare
errSave
A phase II study of tipifarnib and gemcitabine in metastatic breast cancer
err2018-01-27
err19
PREAI
errYam, Clinton; Murthy, Rashmi K.; Valero, Vicente; Szklaruk, Janio; Shroff, Girish S.; Stalzer, Carol J.; Buzdar, Aman U.; Murray, James L.; Yang, Wei; Hortobagyi, Gabriel N.; Moulder, Stacy L.; Arun, Banu
errShare
errSave
Genomic characterization of HER2-positive breast cancer and response to neoadjuvant trastuzumab and chemotherapy-results from the ACOSOG Z1041 (Alliance) trial
err2017-05-01
err55
errOAAI
errLesurf, R.; Griffith, O. L.; Griffith, M.; Hundal, J.; Trani, L.; Watson, M. A.; Aft, R.; Ellis, M. J.; Ota, D.; Suman, V. J.; Meric-Bernstam, F.; Leitch, A. M.; Boughey, J. C.; Unzeitig, G.; Buzdar, A. U.; Hunt, K. K.; Mardis, E. R.
errShare
errSave
SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER plus breast cancer: genome-wide association studies of the estrone pathway
err2017-04-20
err18
errOAAI
errDudenkov, Tanda M.; Ingle, James N.; Buzdar, Aman U.; Robson, Mark E.; Kubo, Michiaki; Ibrahim-zada, Irada; Batzler, Anthony; Jenkins, Gregory D.; Pietrzak, Tracy L.; Carlson, Erin E.; Barman, Poulami; Goetz, Matthew P.; Northfelt, Donald W.; Moreno-Aspita, Alvaro; Williard, Clark V.; Kalari, Krishna R.; Nakamura, Yusuke; Wang, Liewei; Weinshilboum, Richard M.
errShare
errSave
Long-term comparison of anastrozole versus tamoxifen: Results from LATTE/ATAC
err2017-02-15
err0
errOAAI
errCuzick, J.; Sestak, I.; Bianco, A.; Strobbe, L.; Bergh, J.; Hanusch, C.; Neven, P.; Dowsett, M.; Forbes, J. F.; Buzdar, A.; Smith, R.; Howell, A.
errShare
errSave
CSMD1 SNPs selectively affect anastrozole response in postmenopausal breast cancer patients
err2017-02-15
err1
PREAI
errCairns, J.; Ingle, J.; Dudenkov, T.; Kalari, K.; Buzdar, A.; Kubo, M.; Robson, M.; Ellis, M.; Goss, P.; Shepherd, L.; Goetz, M.; Weinshilboum, R.; Wang, L.
errShare
errSave
Risk of acute myeloid leukemia and myelodysplastic syndrome among older women receiving anthracycline-based adjuvant chemotherapy for breast cancer on Modern Cooperative Group Trials (Alliance A151511)
err2016-11-19
err14
errOAAI
errFreedman, Rachel A.; Seisler, D. K.; Foster, J. C.; Sloan, J. A.; Lafky, J. M.; Kimmick, G. G.; Hurria, A.; Cohen, H. J.; Winer, E. P.; Hudis, C. A.; Partridge, A. H.; Carey, L. A.; Jatoi, A.; Klepin, H. D.; Citron, M.; Berry, D. A.; Shulman, L. N.; Buzdar, A. U.; Suman, V. J.; Muss, H. B.
errShare
errSave
errShare
errSave
Identification of early breast cancer patient cohorts who may benefit from lapatinib therapy
err2016-03-01
err4
PREAI
errStrasser-Weippl, Kathrin; Horick, Nora; Smith, Ian E.; O'Shaughnessy, Joyce; Ejlertsen, Bent; Boyle, Frances; Buzdar, Aman U.; Fumoleau, Pierre; Gradishar, William; Martin, Miguel; Moy, Beverly; Piccart-Gebhart, Martine; Pritchard, Kathleen I.; Lindquist, Deborah; Rappold, Erica; Finkelstein, Dianne M.; Goss, Paul E.
errShare
errSave
Long-term hazard of recurrence in HER2+breast cancer patients untreated with anti-HER2 therapy
err2015-04-16
err26
errOAAI
errStrasser-Weippl, Kathrin; Horick, Nora; Smith, Ian E.; O'Shaughnessy, Joyce; Ejlertsen, Bent; Boyle, Frances; Buzdar, Aman U.; Fumoleau, Pierre; Gradishar, William; Martin, Miguel; Moy, Beverly; Piccart-Gebhart, Martine; Pritchard, Kathleen I.; Lindquist, Deborah; Rappold, Erica; Finkelstein, Dianne M.; Goss, Paul E.
errShare
errSave
Health related quality of life of women in TEACH, a randomised placebo controlled adjuvant trial of lapatinib in early stage Human Epidermal Growth Factor Receptor (HER2) overexpressing breast cancer
err2015-04-01
err11
PREAI
errBoyle, Frances M.; Smith, Ian E.; O'Shaughnessy, Joyce; Ejlertsen, Bent; Buzdar, Aman U.; Fumoleau, Pierre; Gradishar, William; Martin, Miguel; Moy, Beverly; Piccart-Gebhart, Martine; Pritchard, Kathleen I.; Lindquist, Deborah; Amonkar, Mayur; Huang, Yingjie; Rappold, Erica; Williams, Lisa S.; Wang-Silvanto, Jing; Kaneko, Tomomi; Finkelstein, Dianne M.; Goss, Paul E.
errShare
errSave
Locoregional Recurrence Risk for Patients With T1,2 Breast Cancer With 1-3 Positive Lymph Nodes Treated With Mastectomy and Systemic Treatment
err2014-06-01
err117
PREAI
errMcBride, Andrew; Allen, Pamela; Woodward, Wendy; Kim, Michelle; Kuerer, Henry M.; Drinka, Eva Katherine; Sahin, Aysegul; Strom, Eric A.; Buzdar, Aman; Valero, Vicente; Hortobagyi, Gabriel N.; Hunt, Kelly K.; Buchholz, Thomas A.
errShare
errSave
Which threshold for ER positivity? a retrospective study based on 9639 patients
err2014-05-01
err186
errOAAI
errYi, M.; Huo, L.; Koenig, K. B.; Mittendorf, E. A.; Meric-Bernstam, F.; Kuerer, H. M.; Bedrosian, I.; Buzdar, A. U.; Symmans, W. F.; Crow, J. R.; Bender, M.; Shah, R. R.; Hortobagyi, G. N.; Hunt, K. K.
errShare
errSave
Pathologic complete response to neoadjuvant chemotherapy with trastuzumab predicts for improved survival in women with HER2-overexpressing breast cancer
err2013-08-01
err70
errOAAI
errKim, M. M.; Allen, P.; Gonzalez-Angulo, A. M.; Woodward, W. A.; Meric-Bernstam, F.; Buzdar, A. U.; Hunt, K. K.; Kuerer, H. M.; Litton, J. K.; Hortobagyi, G. N.; Buchholz, T. A.; Mittendorf, E. A.
errShare
errSave
Immunohistochemical BAG1 expression improves the estimation of residual risk by IHC4 in postmenopausal patients treated with anastrazole or tamoxifen: a TransATAC study
err2013-07-13
err14
PREAI
errAfentakis, Maria; Dowsett, Mitch; Sestak, Ivana; Salter, Janine; Howell, Tony; Buzdar, Aman; Forbes, John; Cuzick, Jack
errShare
errSave
Tamoxifen therapy for patients with breast cancer
errLANCET
IF88.5
err2013-06-01
err2
PREAI
errLitton, Jennifer; Buzdar, Aman; Mac Gregor, Mariana Chavez; Gonzalez-Angulo, Ana; Hortobagyi, Gabriel
errShare
errSave